miRNAs and androgen deprivation therapy for prostate cancer.

Konoshenko, Maria Yu; Bryzgunova, Olga E; Laktionov, Pavel P

Konoshenko, Maria Yu; Bryzgunova, Olga E; Laktionov, Pavel P.

Afiliação

Konoshenko MY; Institute of Chemical Biology and Fundamental Medicine, Siberian Branch, Russian Academy of Sciences, Novosibirsk 630090, Russia. Electronic address: msol@ngs.ru.
Bryzgunova OE; Institute of Chemical Biology and Fundamental Medicine, Siberian Branch, Russian Academy of Sciences, Novosibirsk 630090, Russia.
Laktionov PP; Institute of Chemical Biology and Fundamental Medicine, Siberian Branch, Russian Academy of Sciences, Novosibirsk 630090, Russia.

Biochim Biophys Acta Rev Cancer ; 1876(2): 188625, 2021 12.

Article em En | MEDLINE | ID: mdl-34534639

Assuntos

Antagonistas de Androgênios/uso terapêutico; MicroRNAs/metabolismo; Neoplasias da Próstata/tratamento farmacológico; Antagonistas de Androgênios/farmacologia; Humanos; Masculino

Palavras-chave

ADT; Androgen deprivation therapy; Castration-resistant prostate cancer; Prostate cancer; Therapy effectiveness; miRNA markers

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / MicroRNAs / Antagonistas de Androgênios Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google